Relevant bibliographies by topics / Leishmaniose – Vaccination

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'Leishmaniose – Vaccination'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Leishmaniose – Vaccination.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Leishmaniose – Vaccination"

1

HUGNET, Christophe, Jean-Loup LEMESRE, Gérard PAPIEROK, and Gilles BOURDOISEAU. "Résultats de la vaccination contre la leishmaniose canine (Leishmania infantum) en zone d'enzootie." Bulletin de l'Académie vétérinaire de France, no. 1 (2006): 127. http://dx.doi.org/10.4267/2042/47822.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Minodier, P., F. Faraut-Gambarelli, C. Nicaise, C. Gire, J. M. Garnier, and H. Dumon. "La vaccination contre les leishmanioses." Médecine et Maladies Infectieuses 30, no. 3 (2000): 141–45. http://dx.doi.org/10.1016/s0399-077x(00)88803-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

de Cosmo, A., D. Mazzoni, A. Canati, GE Magi, and D. Beghelli. "Cutaneous leishmaniosis in a dog vaccinated with LiESP/QA-21: effective or defective vaccine-related immune surveillance? A case report." Veterinární Medicína 62, No. 1 (2017): 48–51. http://dx.doi.org/10.17221/48/2016-vetmed.

Full text
Abstract:
Leishmania, an intracellular protozoan parasite, is endemic, widespread and represents a public health problem in most countries of the Mediterranean basin as it is implicated in a wide spectrum of diseases both in humans and animals. Vaccination of canines remains the best control strategy to counteract the progression of active infection for canine disease in areas of the world where transmission to humans is primarily zoonotic. This case report describes the history of a four-year-old dog vaccinated against canine leishmaniosis that was presented to a private clinic for the onset of a nodul
APA, Harvard, Vancouver, ISO, and other styles
4

Martínez-Rodrigo, Abel, Alicia Mas, Daniel Álvarez-Campos, José A. Orden, Gustavo Domínguez-Bernal, and Javier Carrión. "Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way." Vaccines 8, no. 3 (2020): 352. http://dx.doi.org/10.3390/vaccines8030352.

Full text
Abstract:
Visceral leishmaniosis (VL) caused by Leishmania infantum is a disease with an increasing prevalence worldwide. Treatments are expensive, toxic, and ineffective. Therefore, vaccination seems to be a promising approach to control VL. Peptide-based vaccination is a useful method due to its stability, absence of local side effects, and ease of scaling up. In this context, bioinformatics seems to facilitate the use of peptides, as this analysis can predict high binding affinity epitopes to MHC class I and II molecules of different species. We have recently reported the use of HisAK70 DNA immunizat
APA, Harvard, Vancouver, ISO, and other styles
5

Olobo, J. O., C. O. Anjili, M. M. Gicheru, et al. "Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania ‘major surface glycoprotein’ (gp63)." Veterinary Parasitology 60, no. 3-4 (1995): 199–212. http://dx.doi.org/10.1016/0304-4017(95)00788-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Velez, R., E. Domenech, J. Cairó, and M. Gállego. "The impact of canine leishmaniosis vaccination with Canileish® in Leishmania infantum infection seroprevalence studies." Acta Tropica 202 (February 2020): 105259. http://dx.doi.org/10.1016/j.actatropica.2019.105259.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

IBORRA, S. "Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis." Vaccine 22, no. 29-30 (2004): 3865–76. http://dx.doi.org/10.1016/j.vaccine.2004.04.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wylie, C. E., M. Carbonell-Antoñanzas, E. Aiassa, et al. "A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: Vaccinations." Preventive Veterinary Medicine 117, no. 1 (2014): 7–18. http://dx.doi.org/10.1016/j.prevetmed.2014.06.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bretscher, P. A., N. Ismail, J. N. Menon, C. A. Power, J. Uzonna, and G. Wei. "Vaccination against and treatment of tuberculosis, the leishmaniases and AIDS: perspectives from basic immunology and immunity to chronic intracellular infections." Cellular and Molecular Life Sciences CMLS 58, no. 12 (2001): 1879–96. http://dx.doi.org/10.1007/pl00000824.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Thapa, Rinez, Subhasish Mondal, Joakim Riikonen, et al. "Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis." PLOS Neglected Tropical Diseases 15, no. 6 (2021): e0009533. http://dx.doi.org/10.1371/journal.pntd.0009533.

Full text
Abstract:
Visceral leishmaniasis is a vector-borne protozoan infection that is fatal if untreated. There is no vaccination against the disease, and the current chemotherapeutic agents are ineffective due to increased resistance and severe side effects. Buparvaquone is a potential drug against the leishmaniases, but it is highly hydrophobic resulting in poor bioavailability and low therapeutic efficacy. Herein, we loaded the drug into silicon nanoparticles produced from barley husk, which is an agricultural residue and widely available. The buparvaquone-loaded nanoparticles were several times more select
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Leishmaniose – Vaccination"

1

Fragaki, Konstantina. "Protéines de Leishmania infantum : PapLe22, étude de sa capacité vaccinale : Lepp 12, identification et étude de son rôle potentiel dans la dérégulation de la cellule hôte." Nice, 2002. http://www.theses.fr/2002NICE5795.

Full text
Abstract:
Le travail de cette thèse qui porte sur la leishmaniose viscérale à L. Infantum, maladie parasitaire mortelle en l’absence de traitement, endémique sur le pourtour du bassin méditerranéen comporte deux volets principaux. Le premier est constitué par un essai vaccinal, réalisé avec l’ADNc de l’antigène papLe22, précédemment caractérisé au laboratoire. Cet antigène fortement immunogène, stimule in vitro la production d’IL-10, cytokine de la voie Th2 favorisant l’infection ? L’immunisation a permis de réorienter la réponse vers la voie Th1 et de contrôler partiellement la multiplication parasitai
APA, Harvard, Vancouver, ISO, and other styles
2

Michel, Grégory. "Leishmaniose à Leishmania infantum : portage asymptomatique, vaccination par voie endonasale et apport de la bioluminescence." Thesis, Aix-Marseille 2, 2011. http://www.theses.fr/2011AIX20723.

Full text
Abstract:
La leishmaniose viscérale (LV) à Leishmania infantum est une zoonose qui sévit notamment autour du bassin méditerranéen. Elle atteint principalement le chien, qui représente le réservoir de l’infection. Chez l’homme, si la forme patente est rare, il existe de nombreux sujets porteurs asymptomatiques dans les zones d’endémies. Au cours de ce travail, nous avons abordé 3 problématiques importantes concernant la LV. La première problématique à porté sur l’importance du portage asymptotique humain à L. infantum au niveau mondial et de ses conséquences. Notre étude montre que la fréquence de porteu
APA, Harvard, Vancouver, ISO, and other styles
3

Mille, Mireille. "Application de la methode elisa au suivi sero-immunologique d'une population canine vaccinee contre la leishmaniose." Aix-Marseille 2, 1989. http://www.theses.fr/1989AIX20905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Benhnini, Fouad. "Leishmaniose expérimentale murine : impact de la diversité génétique des lignées de souris sur les réponses immunes innée et vaccinale." Paris 6, 2009. http://www.theses.fr/2009PA066007.

Full text
Abstract:
Trois nouvelles lignées de souris issues de parentaux sauvages ont été récemment décrites comme étant résistantes (MBT) ou sensibles (MAI et PWK) à l’infection par Leishmania (L. ) major. Fait notable, les mécanismes physiopathologiques de l’infection leishmanienne chez ces souris apparaissent différents de ceux décrits chez les souris BALB/c et C57BL/6, qui représentent le modèle canonique de leishmaniose expérimentale. Ces différences reflètent logiquement la diversité des fonds génétiques propres à chacune de ces cinq lignées. Tirant bénéfice de ces nouveaux modèles de leishmaniose expérime
APA, Harvard, Vancouver, ISO, and other styles
5

Soutter, Francesca. "Canine leishmaniosis : immunogenetics of response to infection and vaccination." Thesis, Royal Veterinary College (University of London), 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701667.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Velez, Maria Rita Perdigão. "Epidemiology and control of canine leishmaniosis: characterization of a previously undescribed endemic area in Catalonia and CaniLeish® vaccine field trial." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/664654.

Full text
Abstract:
Leishmaniosis is an important vector-borne zoonosis caused by Leishmania infantum. The disease is widespread across several continents and endemic in the Mediterranean region. The domestic dog is the main vertebrate reservoir for the parasite and control of canine leishmaniosis (CanL) is deemed to be essential for the control of human cases of the disease. Due to the heterogeneous distribution of infection in endemic areas, epidemiological surveillance should be carried out focally, including both screening of canine populations and vector detection, the two determinant factors for parasite su
APA, Harvard, Vancouver, ISO, and other styles
7

Okwor, Ifeoma Benedette. "Maintenance and loss of immunologic memory in cutaneous leishmaniases : implications for vaccine design and vaccination strategies." 2008. http://hdl.handle.net/1993/21240.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Leishmaniose – Vaccination"

1

Schnur, L. F. "Premunition, A Possible Limitation in the Prevention of the Leishmaniases by Vaccination." In Leishmaniasis. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1575-9_46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Leishmaniose – Vaccination' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography